Rilzabrutinib

Item number	Size	Delivery time	Price
TGM-T12542-1mg	1 mg	7 - 10 business days*	95.00€
TGM-T12542-5mg	5 mg	7 - 10 business days*	233.00€
TGM-T12542-1mL	1 ml	7 - 10 business days*	341.00€
TGM-T12542-10mg	10 mg	7 - 10 business days*	374.00€
TGM-T12542-25mg	25 mg	7 - 10 business days*	652.00€
TGM-T12542-50mg	50 mg	7 - 10 business days*	940.00€
TGM-T12542-100mg	100 mg	7 - 10 business days*	1,317.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Rilzabrutinib (PRN1008) is a reversible covalent, selective, and orally active... more

Close menu

Product information "Rilzabrutinib"

Description: Rilzabrutinib (PRN1008) is a reversible covalent, selective, and orally active inhibitor of Bruton's Tyrosine Kinase (BTK) with an IC50 of 1.3 nM. Target: Others, BTK, HER, EGFR. Smiles: CC(C)(\C=C(/C#N)C(=O)N1CCC[C@H](C1)n1nc(-c2ccc(Oc3ccccc3)cc2F)c2c(N)ncnc12)N1CCN(CC1)C1COC1. References: Smith PF, et al. A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers. Br J Clin Pharmacol. 2017 Nov,83(11):2367-2376.

Keywords:	PRN1008
Supplier:	TargetMol
Supplier-Nr:	T12542

Properties

MW:	665.76 D
Formula:	C36H40FN9O3

Database Information

CAS :

1575596-29-0| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Rilzabrutinib"

Write a review